National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2019 (No. 11) (PB 94 of 2019) (Cth)

PB 94 of 2019

National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2019 (No. 11)

National Health Act 1953

___________________________________________________________________________

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated 27^th November 2019

THEA DANIEL

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

___________________________________________________________________________

1. Name of Instrument

(1)This Instrument is the National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2019 (No. 11).

(2)This Instrument may also be cited as PB 94 of 2019.

1. Commencement

This Instrument commences on 1 December 2019.

1. Amendment of National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015)

Schedule 1 amends the National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015).

Schedule 1       Amendments

1. Schedule 1, after entry for Dipyridamole with aspirin

insert:

Dolutegravir with lamivudine Tablet containing dolutegravir 50 mg (as sodium) with lamivudine 300 mg 20 60 5

1. Schedule 1, after entry for Riluzole

insert:

Risankizumab Injection 75 mg in 0.83 mL pre-filled syringe 20 2 1

1. Schedule 1, entry for Sevelamer

insert as first entry:

Tablet containing sevelamer carbonate 800 mg 20 180 5